Study Finds New Version of QIAGEN’s HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer

Research demonstrating the potential of a special type of HPV test developed by QIAGEN with support from PATH — a non-profit global health organization — to reduce the incidence of cervical cancer in low-resource regions of the world were presented this week at the 24th International Papillomavirus Conference in Beijing, People’s Republic of China.
CNN Money